{"id":"W2810908182","doi":"10.1093/rheumatology/key161","title":"Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)","year":2018,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Psoriatic arthritis; Visual analogue scale; Placebo; Physical therapy; Randomized controlled trial; Adalimumab; Psoriasis; Internal medicine; Arthritis; Dermatology; Alternative medicine; Secukinumab; Rheumatoid arthritis; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006900708,0.0002913156,0.0005913796,0.0001065469,0.0001409504,0.0002453176,0.0001695126,0.000227834,0.001604919],"category_scores_gemma":[0.0006436009,0.000132469,0.0004429834,0.0001145061,0.0001108777,0.0002347597,0.0001775912,0.0004959428,0.0002539362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001135645,"about_ca_system_score_gemma":0.0001385333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001823068,"about_ca_topic_score_gemma":0.0004288641,"domain_scores_codex":[0.9998152,0.00006913229,0.0000188223,0.00003006602,0.00003234108,0.00003447421],"domain_scores_gemma":[0.9997031,0.00006127109,0.0001171199,0.00002262467,0.00001766318,0.00007820677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3351023,0.02342278,0.1155466,0.001811881,0.002154915,0.0004906529,0.0004360375,0.003278007,0.08584175,0.0001048345,0.004635339,0.4271749],"study_design_scores_gemma":[0.08312381,0.3811499,0.5184621,0.0001268532,0.001395847,0.0009971106,0.0001555952,0.002548959,0.009116432,0.0001550351,0.002721695,0.00004682158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983382,0.0008820134,0.00005802361,0.00005484801,0.00001510428,0.0000369568,0.0001375825,0.00001665862,0.0004604895],"genre_scores_gemma":[0.9988316,0.0002973318,0.0001357975,0.00008728919,0.00002001476,0.00003488777,0.0002481942,0.000001635937,0.0003432591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001604919,"threshold_uncertainty_score":0.005368948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009726416930599485,"score_gpt":0.2563117587907305,"score_spread":0.2465853418601311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}